Compounds > glutamine

glutamine and Squamous Cell Carcinoma of Head and Neck

glutamine has been researched along with Squamous Cell Carcinoma of Head and Neck in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (30.77)24.3611
2020's9 (69.23)2.80

Authors

AuthorsStudies
Barbeau, LMO; Bussink, J; de Jong, MC; Keulers, TG; Koch, A; Melotte, V; Rouschop, KMA; Savelkouls, KGM; van Gisbergen, MW; Wanders, RG; Zonneveld, MI1
Guo, B; Han, Y; He, Y; Liu, L; Liu, S; Xu, S; Zhang, X1
Higaki, Y; Kunitake, N; Kuroki, K; Masuda, M; Rikimaru, F; Toh, S1
Aoki, D; Banno, K; Kawaguchi, S; Masuko, T; Minami, Y; Nagano, O; Nakayama, H; Okazaki, S; Otsuki, Y; Saya, H; Suina, K; Umene, K; Yamasaki, J; Yoshikawa, M1
Huang, Y; Jin, R; Liu, R; Luo, J; Shuai, Y; Wang, X; Zhang, Z1
Cheng, B; Fan, Z; Hu, Q; Li, W; Ling, Z; Luo, Y; Tao, X1
Al-Ameer, HJ; Al-Rawashdeh, B; Almasri, Y; Hijazi, E; Jarrar, Y; Shomaf, M; Sobiahe, A; Zihlif, M1
Chen, S; Li, S; Qian, C; Wang, Y; Yao, J1
Gao, Z; Guan, J; Huang, W; Li, N; Liu, F; Liu, Y; Wang, F; Wang, S; Wang, X; Xu, C; Yi, H; Zhang, N; Zhang, X1
Abu-Zaid, A; Alqahtani, KH; Alsini, AY; Alsubaie, HM; Alsubaie, KM; Alzahrani, FR; Pathak, AK; Sayed, S1
Baer-Dubowska, W; Kleszcz, R; Krajka-Kuźniak, V; Paluszczak, J1
Fan, Z; Li, X; Lu, H; Lu, Y; Qiu, S1
Davis-Malesevich, M; Fokt, I; Frederick, MJ; Myers, JN; Ow, TJ; Pickering, CR; Priebe, W; Sandulache, VC; Zhou, G1

Reviews

1 review(s) available for glutamine and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Glutamine for prevention and alleviation of radiation-induced oral mucositis in patients with head and neck squamous cell cancer: Systematic review and meta-analysis of controlled trials.
    Head & neck, 2021, Volume: 43, Issue:10

    Topics: Glutamine; Head and Neck Neoplasms; Humans; Radiation Injuries; Randomized Controlled Trials as Topic; Squamous Cell Carcinoma of Head and Neck; Stomatitis

2021

Trials

1 trial(s) available for glutamine and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study.
    Clinical nutrition ESPEN, 2023, Volume: 57

    Topics: Arginine; Cachexia; Chemoradiotherapy; Glutamine; Head and Neck Neoplasms; Humans; Mucositis; Squamous Cell Carcinoma of Head and Neck

2023

Other Studies

11 other study(ies) available for glutamine and Squamous Cell Carcinoma of Head and Neck

ArticleYear
ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer.
    Autophagy, 2022, Volume: 18, Issue:8

    Topics: Animals; Autophagy; Autophagy-Related Protein 12; Fibroblasts; Glutamine; Head and Neck Neoplasms; Humans; Mice; Squamous Cell Carcinoma of Head and Neck; Tumor Hypoxia; Tumor Microenvironment; Vascular Endothelial Growth Factor A

2022
MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30.
    Cellular & molecular biology letters, 2022, Dec-06, Volume: 27, Issue:1

    Topics: Carcinoma, Squamous Cell; Glutamine; Head and Neck Neoplasms; Humans; Mitochondrial Proteins; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Thiolester Hydrolases

2022
Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
    Cancer science, 2019, Volume: 110, Issue:11

    Topics: Amino Acid Transport System ASC; Amino Acid Transport System y+; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cisplatin; Glutamate Dehydrogenase; Glutamine; Glutathione; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Ketoglutaric Acids; Metabolome; Mice; Mice, Nude; Minor Histocompatibility Antigens; Mitochondria; Molecular Targeted Therapy; Neoplastic Stem Cells; Oxidation-Reduction; Oxidative Stress; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Sulfasalazine

2019
ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
    British journal of cancer, 2020, Volume: 122, Issue:1

    Topics: Amino Acid Transport System ASC; Animals; Antineoplastic Agents, Immunological; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cetuximab; Disease Progression; Female; Glutamine; Head and Neck Neoplasms; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Nude; Minor Histocompatibility Antigens; Oxidative Stress; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Transfection; Tumor Burden; Xenograft Model Antitumor Assays

2020
ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells.
    Cancer medicine, 2020, Volume: 9, Issue:10

    Topics: Aged; Amino Acid Transport System ASC; Animals; Cell Line, Tumor; Cell Proliferation; Female; Gene Knockdown Techniques; Glutaminase; Glutamine; Glutathione; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Middle Aged; Minor Histocompatibility Antigens; Mouth Neoplasms; Neoplasm Transplantation; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck

2020
Arg399Gln XRCC1 Polymorphism and Risk of Squamous Cell Carcinoma of the Head and Neck in Jordanian Patients.
    Asian Pacific journal of cancer prevention : APJCP, 2020, Mar-01, Volume: 21, Issue:3

    Topics: Adult; Aged; Arginine; Female; Glutamine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Squamous Cell Carcinoma of Head and Neck; X-ray Repair Cross Complementing Protein 1

2020
Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR‑330‑3p/GLS axis.
    Oncology reports, 2021, Volume: 45, Issue:4

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Knockdown Techniques; Glutaminase; Glutamine; Humans; MicroRNAs; Neoplasm Invasiveness; RNA, Circular; Squamous Cell Carcinoma of Head and Neck; Tongue; Tongue Neoplasms; Up-Regulation

2021
A novel tumor suppressor CECR2 down regulation links glutamine metabolism contributes tumor growth in laryngeal squamous cell carcinoma.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:9

    Topics: Aged; Aged, 80 and over; Animals; Cell Count; Cell Line, Tumor; Cell Proliferation; Disease Progression; Down-Regulation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glutamine; Humans; Ketoglutaric Acids; Laryngeal Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Mitochondria; Neoplasm Proteins; Oxygen Consumption; Squamous Cell Carcinoma of Head and Neck; Transcription Factors

2021
The inhibition of c-MYC transcription factor modulates the expression of glycolytic and glutaminolytic enzymes in FaDu hypopharyngeal carcinoma cells.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2018, Volume: 27, Issue:6

    Topics: Cell Line, Tumor; Cell Survival; Glutamine; Glycolysis; Humans; Hypopharyngeal Neoplasms; Proto-Oncogene Proteins c-myc; Squamous Cell Carcinoma of Head and Neck; Thiazoles

2018
ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
    Cancer letters, 2016, 10-10, Volume: 381, Issue:1

    Topics: Amino Acid Transport System ASC; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Dichloroacetic Acid; Down-Regulation; Endocytosis; ErbB Receptors; Gefitinib; Glutamine; Glutathione; Head and Neck Neoplasms; Humans; Minor Histocompatibility Antigens; Oxidative Stress; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Quinazolines; Reactive Oxygen Species; RNA Interference; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Time Factors; Transfection

2016
Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.
    Cancer, 2011, Jul-01, Volume: 117, Issue:13

    Topics: Adenosine Triphosphate; Carcinoma; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Deoxyglucose; Disease Progression; Genes, p53; Glucose; Glutamine; Head and Neck Neoplasms; Humans; Lactic Acid; Mass Spectrometry; Metabolomics; Metformin; Neoplasms, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Suppressor Protein p53

2011